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Available online 18 March 2017With the aim to produce, by a simple and reproducible technique, porous scaffolds potentially employable for tis-
sue engineering purposes, in this work, we have synthesized a methacrylate (MA) copolymer of α,β-poly(N-2-
hydroxyethyl)-DL-aspartamide (PHEA) and polylactic acid (PLA). PHEA-PLA-MA has been dissolved in organic
solvent at different concentrations in the presence of NaCl particles with different granulometry, and through
UV irradiation and further salt leaching technique, various porous scaffolds have been prepared. Obtained sam-
ples have been characterized by scanning electron microscopy and their porosity has been evaluated as well as
their degradation proﬁle in aqueous medium in the absence or in the presence of esterase from porcine liver.
PHEA-PLA-MA scaffold that has shown homogeneous porosity and the best degradation proﬁle has been further
characterized to study its mechanical properties along with its capacity to incorporate and to control the release
of dexamethasone. Finally, the ability to allow a three-dimensional culture of bovine articular chondrocytes have
been also investigated.





The morphology of a scaffold for tissue engineering is of crucial im-
portance for a correct spatial distribution of cells, for their anchoring
and spreading and also to make the construct itself able to resist to me-
chanical stimulations of the body area which should be regenerated.
In principle, an ideal scaffold should represent a temporary substi-
tute of extracellular matrix (ECM) that can be colonized in vitro or
in vivo by cells able to produce new ECM components, essential for
the restoration of physiological conditions.
In addition, the physicochemical and morphological properties of
the scaffold, such as its swelling behavior and its porosity, could facili-
tate the exchange of nutrients/oxygen with the surrounding tissues
and the removal of waste products.
The biomaterials should be processed to give an enough porous
structure for efﬁcient nutrient and metabolite transport without signif-
icantly compromising the mechanical stability of the scaffold [1].ers, Dipartimento di Scienze e
BICEF), Sezione di Chimica e
o, Italy.In fact, even if a substantial scaffold porosity is necessary to allow the
cell distribution, mechanical properties are often inversely proportional
to the degree of porosity [2].
An ideal scaffold should showmechanical properties similar to those
of natural tissues, biocompatibility and a controlled degradation rate to-
gether with the ability to entrap and to release speciﬁc bioactive factors
for improving regeneration process [3,4].
Many biomaterial processing techniques, such as sonication [5],
electrospinning [6,7], thermally induced phase separations (TIPS) [8],
freeze drying [9], salt leaching [10], gas foaming [11] and 3D printing
[12], have been employed in recent years to obtain porous structures
for various biomedical applications.
If on one hand the preformation of a porous scaffold allows to ﬁnely
control its morphological characteristic in terms for example of pores
dimension and shape, on the other hand the use of these devices
needs often an invasive surgical implantation that, could lead to devel-
opment of infections and involves longer recovery times.
However, preformed porous scaffolds are often desirable to guaran-
tee a uniform three dimensional distribution of the implanted cells and
their high surface area can be exploited for the release of different drugs
[13].
For example, Saber-Samandari et al., developed very recently
chitosan-graft-poly(acrylic acid-co-acrylamide) based porous scaffolds
for bone tissue engineering through the freeze drying process. They
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mal characteristics as drug delivery systems [14].
Still, Fereshteh et al. developed porous scaffolds for tissue engineer-
ing purposes from poly(ε-caprolactone) and zein and they demonstrat-
ed that these devices can control the release of tetracycline
hydrochloride [15].
In this last case, authors demonstrated also that the presence of zein
was crucial to control the degradation proﬁle of the scaffold. This is a
crucial aspect because, beside the morphology of the scaffold, also the
structure of starting biomaterial is important since it inﬂuences the ca-
pacity of the construct to interact with body ﬂuids, its mechanical prop-
erties and its biodegradability.
Here our aim was to propose a facile and reproducible technique to
obtain porous scaffolds for potential cartilage tissue engineering pur-
poses, exploiting the combination between UV crosslinking and salt
leachingprocedures and employing, as a starting biomaterial, an amphi-
philic copolymer obtained by grafting polylactic acid (PLA) toα,β poly-
(N-2-hydroxyethyl)-DL-aspartamide (PHEA).
Generally, polyesters, promote cell adhesion, give optimal mechani-
cal properties to scaffolds but they showpoor afﬁnity towards biological
ﬂuids, due to their low hydrophilic character [16]. On the contrary,
PHEA is a biocompatible and water soluble polyaminoacid, widely
employed for the production of several devices for tissue engineering
[17–19].
In previous papers it has been demonstrated that the presence of
synthetic polyaminoacids appropriately allowed to tune cell adhesive-
ness together with chemical, physical and mechanical properties [20,
21].
Therefore, the combination of the physico-chemical properties of
PLA and PHEA could be useful to produce scaffolds with appropriate
mechanical properties together with a good afﬁnity towards the cells
and the physiological medium.
In this paper, for the ﬁrst time, PHEA-PLA was functionalized with
methacrylic anhydride (MA) to obtain a UV photocrosslinkable copoly-
mer (named PHEA-PLA-MA) employable as a starting material for the
production of porous scaffolds.
By changing the production parameters, a series of different scaf-
folds was obtained.
The scaffold that has shown homogeneous porosity and the best
degradation proﬁle has been chosen to incorporate and to culture bo-
vine articular chondrocytes as well as to incorporate and to control
the release of dexamethasone, a drug employed in the treatment of os-
teoarthritis [22] for its anti-inﬂammatory properties and for its capacity
to stimulate the differentiation of stem cells into chondrocytes and/or
osteoblasts [23,24].
A scaffold that controls the release of dexamethasone should be po-
tentially able to reduce the chronic inﬂammation process and, at the
same time, to stimulate themesenchymal stem cells of the surrounding
tissues to differentiate in order to restore the tissue homeostasis.2. Experimental section
2.1. Materials and methods
Dimethyl sulfoxide (DMSO), N,N-dimethyl formamide
(DMF), dichloromethane, (DCM), hexamethyldisilazane, 1,1′-
Carbonyldiimidazole (CDI), 4-(Dimethylamino)pyridine (DMAP), dexa-
methasone, esterase from porcine liver, Dulbecco's Modiﬁed Eagle's
Medium (DMEM), Dulbecco's phosphate buffered saline (DPBS),
trypsin–EDTA solution, amphotericin B solution, penicillin-
streptomycin and fetal bovine serum (FBS) were purchased from
Sigma-Aldrich (Italy). Diethylamine (DEA) and methacrylic anhydride
(MA) were purchased from Fluka (Italy).
CellTiter 96® AQueous One Solution Cell Proliferation Assay (for
MTS assay) was purchased from Promega.RESOMER R 202 (D,L polylactic acid, PLA 14 kDa) was purchased
from PURAC.
α,β-Poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA) was prepared
and puriﬁed according to a procedure reported elsewhere [25]. PHEA
weight-average molecular weight was 41 kDa (Mw/Mn= 1.78) as de-
termined by size exclusion chromatography (SEC).
1H NMR spectra were obtained with a Brucker AC-300 instrument.
Freeze drying procedures were conducted employing a LABCONCO
freezone 6 freeze drying system.
Scanning electron microscopy (SEM) was performed using a
Scanning Electron Microscope (ESEM QUANTA FEI 200F) with an
accelerating voltage of 15 kV. For SEM analysis of cell containing
scaffolds, samples were ﬁxed in formaldehyde, dehydrated by
hexamethyldisilazane (Sigma-Aldrich) and dried under vacuum prior
to be gold sputtered and analyzed.
UV irradiation was performed using a Rayonet reactor equipped
with a Rayonet Carousel motor assembly and 16 mercury lamps of
8 W at medium pressure with an emission at 366 nm.
UV analysis was performed with a UV–VIS 2401 PC spectrophotom-
eter produced by Shimadsu.
Atomic force microscopy (AFM) was performed using a Bruker
FastScan atomic force microscope.
Compression tests were performed using an Instron apparatus
(Model 3345, Instron, Norwood, MA).
2.2. Synthesis of PHEA-PLA and PHEA-PLA-MA graft copolymers
Derivatization of PHEA with acid terminated PLA to obtain the
PHEA-PLA graft copolymer was carried out by using CDI as a coupling
agent to activate the terminal carboxyl group of PLA by using a proce-
dure already reported with minor modiﬁcations [26].
Brieﬂy, CDI dissolved in DMF was added to a PLA solution in the
same solvent (molar ratio CDI/PLA equal to 1.5); after 4 h of activation
at 40 °C, the PLA activated solution was added to a PHEA solution
(molar ratio PLA/PHEA repetitive units equal to 0.06) in the presence
of DEA as a catalyst (ﬁvefold molar excess respect to PHEA repetitive
units). The reaction was left under argon atmosphere and continuous
stirring at 40 °C for 24 h and then precipitated in pure diethyl ether.
The obtained suspension was centrifuged (9800 rpm for 20 min at 4
°C) and the productwaswashed in diethyl ether:dichloromethanemix-
ture (15:1 v/v) for ﬁve times (30 min per washing), then dried under
vacuum at room temperature and recovered with a yield of 200 wt%
based on the starting PHEA.
For the insertion of methacrylic moieties, 500 mg of PHEA-PLA was
dissolved in 10 ml of DMF in the presence of 167 mg of DMAP (molar
ratio DMAP/PHEA repetitive units equal to 1.2) and 1.7 ml of MA
(molar ratio MA/PHEA repetitive units equal to 10). The reaction was
left under argon atmosphere and continuous stirring for 24 h at 25 °C.
The product was isolated by precipitation in diethyl ether, washed 5
times with the same solvent and dried under vacuum at room temper-
ature. PHEA-PLA-MA copolymer was obtained with a yield of 80 wt%
based on the starting PHEA-PLA.
2.3. 1H NMR analysis
1H NMR analysis was performed by dissolving PHEA-PLA or PHEA-
PLA-MA in DMF-d7 at a concentration of 5 mg/ml. Spectra were record-
ed at 300.12 MHz performing 16 scans per sample with an acquisition
time of 1.36 s per scan.
2.4. Production of PHEA-PLA-MA porous scaffolds
PHEA-PLA-MA was dissolved in DMSO at concentrations of 60 or
80% (w/v).
NaCl with different granulometry (between 60 and 90 μm and be-
tween 90 and 125 μm) was added to the polymeric solutions, setting a
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viscous pastes that were irradiated at 366 nm for 1 h by using a Rayonet
reactor. Scaffolds were washed extensively with double distilled water
in order to eliminate the salt. Porous scaffolds thus obtained (named
as samples A, B, C, D, see Table 1), were freeze dried, gold sputtered
and analyzed by SEM in order to investigate if a uniform porous struc-
ture was obtained for all the produced scaffolds and to choose scaffolds
suitable for further physicochemical and biological characterization.
Table 1 shows the composition of pastes employed for UV
irradiation.
Only the scaffolds for which SEM analysis showed the presence of a
uniform porous structure have been further studied (scaffolds A and C).
2.5. Porosity determination
The determination of porosity was performed as reported by
Hutmacher et al. [27].
Brieﬂy, each freeze dried scaffold was immersed into a known vol-
ume of ethylene glycol (V1) in a graduated cylinder and the volume of
the solvent with the scaffold was measured (V2).
The system has been degassed under vacuum until nomore bubbles
formation was observed, the scaffold was then removed from the cylin-
der and the remaining volume of ethylene glycol was measured again
(V3).
The % of porosity has been determined by using the following equa-
tion:
%of porosity ¼ V1−V3=V2−V3ð Þ  100
Each experiment was performed in triplicate.
Scaffold porosity was also studied using a pycnometer (Pycnomatic
ATC, Thermo Fisher Scientiﬁc, Waltham, Massachusetts, USA). The po-
rosity was measured adopting helium as a penetrating agent. Cubic
specimens were used to accurately evaluate the bulk volume. Knowing
the bulk and the skeletal volume, it is possible to obtain the porosity of
the samples by the following formula:
%of porosity ¼ Vb−Vpð Þ=Vb  100
where Vb is the bulk volume and Vp is the volume calculated by the
pycnometer.
2.6. Studies of hydrolytic and enzymatic degradation
Scaffolds were weighed, immersed into DPBS pH 7.4 alone or in the
presence of esterase (50 U/ml) and incubated in an orbital shaker
(35 rpm) at 37 °C. After scheduled times, samples were washed three
times with double distilled water and freeze-dried. The degradation
was expressed as recovered weight % respect to the starting weight of
each sample calculated as:
Recovered weight% ¼ final weight=initial weightð Þ  100
Each experiment was performed in triplicate.
Only the scaffoldwith higher porosity and better degradation proﬁle
was further studied (scaffold C).Table 1
Composition of pastes containing PHEA-PLA-MA and NaCl in DMSO employed for scaffold
production by their UV irradiation.




D 60% 90–1252.7. Atomic force microscopy (AFM) analysis and compression mechanical
studies
The elastic modulus of the scaffold was determined by AFM micro-
scope using a Bruker TESPA wafer A05615 probe having an optical sen-
sitivity of 80 nm/V and a constant force of 14.65 N/m (calculated after
calibration with sapphire surface).
The cantilever of the probe has a rectangular geometry and a thick-
ness of 4 μm, the tip has a standard geometry with a radius of 8 nm.
Measurements were taken in four different regions of the sample
and loading and unloading curves were obtained with a trig threshold
of 2 nm.
To determine the elastic modulus from the force/separation curves,
the Hertz model has been used, considering, for all the obtained curves,
force boundary between 10 and 70%.
Equine decellularized bone was used as a comparison sample.
Compression mechanical studies were performed on scaffold swol-
len in DPBS pH 7.4, shaped as disks with 10 mm of diameter and
1.5 mm of height. Samples were tested in compression until failure
with a uniform strain rate of 1 mmmin−1 and with a 1 kN load cell.
2.8. Dexamethasone incorporation and release studies
Dexamethasone was dissolved in acetone (10 mg/ml) and the ob-
tained solution was employed to wet the scaffold. The weight ratio be-
tween scaffold and drug was 10:1. Sample was then dried at 37 °C in
orbital shaker for 24 h.
The encapsulation efﬁciency % (EE%) was calculated by comparing
the employed initial amount of dexamethasone with that extracted
from the ﬁlm.
To determine the value EE%, dexamethasone containing scaffoldwas
treated with acetone to dissolve entrapped drug, the organic solvent
was then ﬁltered and the evaporated under vacuum. The obtained res-
idue was dissolved in DPBS pH 7.4 and the concentration of drug was
determined by using a UV spectrophotometer. A calibration curve was
made by diluting a solution of dexamethasone in DPBS pH 7.4 with an
initial concentration of 0.04 mg/ml.
For the release studies, dexamethasone containing scaffold was im-
mersed into DPBS pH 7.4 (50 ml) and at scheduled times, 2 ml of medi-
um were withdrawn for UV analysis and replaced with the same
volume of fresh medium. Each experiment was performed in triplicate.
2.9. Chondrocyte incorporation
Bovine articular chondrocytes were isolated as reported in a previ-
ous work [28].
Cylindrical scaffolds of 5mmdiameter and height were sterilized by
UV irradiation for 1 h using a 125 W UV-lamp and inserted into each
well of 96 well plate.
Chondrocytes were harvested and suspended (10 × 106 cells in
1 ml) in DMEM supplemented with 10% v/v of FBS, 1% v/v of
penicillin–streptomycin solution, 1% v/v of glutamine solution and
0.1% v/v amphotericin B solution.
50 μl of obtained cell suspension were poured into each scaffold,
plateswere incubated for 30min and then each scaffoldwas transferred
into a 48 well plate with 500 μl of culture medium (supplemented
DMEM).
Samples were cultured for 7 and 14 days by refreshing the culture
medium every two days. At scheduled times, the metabolic activity of
incorporated chondrocyteswas evaluated byMTS assay by using suppli-
er instructions and results were expressed as % of cell viability com-
pared to that of chondrocytes cultured in 48 well plate employed as a
positive control. Chondrocytes containing scaffolds were investigated
by scanning electron microscopy (SEM). For this study, at scheduled
times, samples were ﬁxed with 10% v/v formaldehyde, rinsed with
water and dehydrated with ethanol series (30%, 50%, 70%, 90% v/v and
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ﬂow hood.
Dried scaffolds were freeze fractured, situated on the stubs by using
an appropriate adhesive tape, gold coated (thickness of gold coating of
about 20 nm) and analyzed by SEM in order to observe cells inside scaf-
folds. Each experiment was performed in triplicate.
2.10. Statistical analysis
Data are presented as means ± standard deviation, SD. t-Test was
employed for the statistical analysis, p values littler than 0.05were con-
sidered as statistically signiﬁcant.
3. Results
3.1. Synthesis of PHEA-PLA and PHEA-PLA-MA graft copolymers
Synthesis of PHEA-PLA was performed in organic solvent, in the
presence of DEA as a catalyst, by using a molar ratio between PLA and
PHEA repetitive units equal to 0.06.
PHEA-PLA 1H NMR spectrum shows peaks at δ 1.3 and 1.7 (582H of
PLA, 2d: O\\CO\\CH(CH3)\\O\\); 2.9 (2H of PHEA, m:
\\CO\\CH\\CH2\\CO\\NH\\); 3.1, (2H of PHEA, t:
\\NH\\CH2\\CH2\\O\\); 5.1 (194H of PLA,m:\\O\\CO\\CH(CH3)\\),
4.8 (1 of PHEA, m:\\NH\\CH(CO)CH2\\).
Molar functionalization in PLA for PHEA-PLA copolymer was 2 ±
0.5% as calculated by comparing integrals of the peaks at δ 1.3 and 1.7,
attributed to methyl groups of PLA repetitive units, with signals at δ
3.1 and 5.1 attributed to protons of PHEA backbone.
The reaction between PHEA-PLA and methacrylic anhydride (MA)
has been performed in DMF in the presence of DMAP as a catalyst,
under argon and continuous stirring for 24 h. Molar ratio between MA
and PHEA repetitive units was 10.
PHEA-PLA-MA 1H NMR spectrum shows, in addition to the charac-
teristic peaks of PHEA-PLA, also peaks between δ 5.4 to 6.1 attributable
to the protons of the methacrylic moieties.
Molar functionalization inMA in ﬁnal PHEA-PLA-MA copolymerwas
20±2% as calculated by comparing integrals of the peaks between δ 5.4
and 6.1 due to protons of methacrylic moieties, with the signals at δ 3.1
and 5.1 attributed to protons of PHEA backbone. Fig. 1 shows the chem-
ical structure and the 1H NMR spectrum of PHEA-PLA-MA copolymer.Fig. 1. Chemical structure and 1H NMR sp3.2. Production of PHEA-PLA-MA porous scaffolds
The high solubility of PHEA-PLA-MA in DMSO allows to produce vis-
cous pastes composed of concentrated solutions of the copolymer con-
taining undissolved particles of NaCl, chosen as a porogen. By changing
the concentration of the copolymer (60 and 80% w/v) and the
granulometry of salt (60–90 μm and 90–125 μm), four different pastes
have been produced. In all cases, the weight ratio between PHEA-PLA-
MA and NaCl was 30:70.
Table 1 (see Experimental section) shows the composition of pastes
employed for UV irradiation.
For each sample, the crosslinking of PHEA-PLA-MA copolymer was
performed by UV irradiation at 366 nm until each paste shifts from a
semi-solid to a solid form. Under these conditions, the crosslinking pro-
cess start to takes place already after 30min; no signiﬁcant difference in
solidiﬁcation time has been observed for all samples. The
photocrosslinking reaction is showed in Scheme 1.
How it is possible to observe from the Fig. 2, only samples A and C,
namely those obtained using NaCl with lower granulometry, show a
uniform porous structure.
In addition, these scaffolds show an average pore diameter near to
size of NaCl employed in the starting paste and also their inner structure
shows a uniform porosity (see Fig. 3).
Taking into account these results, only scaffolds A and C have been
employed for further characterization.
3.3. Porosity determination
The determination of porosity has been performed by using the liq-
uid displacement method [27]. Results obtained through this analysis
showed that the porosity of sample A and C was 50 ± 4% and 70 ±
6%, respectively.
These results were conﬁrmed by the analysis also performed with
the helium pycnometer (49.3 ± 1.9% and 70.5 ± 2.4, respectively for
sample A and C). The gas pycnometer allows the knowledge of the
real volume of a porous sample, excluding the volume of the pores.
3.4. Studies of hydrolytic and enzymatic degradation
In order to have information about the potential biodegradability of
chosen scaffolds (samples A and C) in physiological medium, their
weight loss after incubation at 37 °C in DPBS pH 7.4 has been evaluated.ectrum of PHEA-PLA-MA copolymer.
Scheme 1. UV triggered crosslinking reaction of PHEA-PLA-MA.
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ence of esterase, ubiquitous enzymes that in vivo could hydrolyze
ester bonds of PLA portions in PHEA-PLA-MA.
As shown in Fig. 4a, the hydrolytic degradation proﬁles of scaffolds A
and C are similar over a period of 7 days, where both samples lose 15%
about of their initial weight. After 14 days, the degradation is signiﬁ-
cantly faster for sample C (p b 0.05) and also after 21 days, its weight
loss is higher than that of sample A (60% against 30% about) (p b 0.05).
Sample C shows a linear trend throughout the period of analysis (y
=−2.8272x+102.64 R2=0.9943)while sample A shows a less linear
proﬁle (y =−1.2368x + 93.755 R2 = 0.9622).
Different research groups have demonstrated in the past years that
primary chondrocytes as well as chondro stimulated mesenchymal
cell, when cultured in 3D scaffold, if healthy, produce abundant new
ECM after 28 days [29,30]. Taking into account these information and
considering our obtained results, we believe that sample C shows better
hydrolytic degradation proﬁle compared to sample A. In fact, thanks toFig. 2. SEM images of porous scaffolds (samples A, B, C, D) obtained byUV irradiation of pastes co
their washing with double distilled water and freeze drying.its faster degradation, the elimination of the implanted material from
the body may occur in tandem with the formation of new tissue [31].
The enzymatic degradation was followed over a period of 7 days to
demonstrate if the investigated scaffolds are susceptible to the action
of physiological enzymes, like esterase.
As shown in Fig. 4b, for each scheduled time, the weight loss of both
scaffolds in the presence of esterase is higher than that observed in
DPBS pH 7.4 alone (30% against 15% about), thus demonstrating that
the presence of enzyme increases the degradation rate.
No signiﬁcant (p N 0.05) differences were observed between the in-
vestigated scaffolds.
According to what reported in literature, an ideal porous scaffold for
tissue engineering purposes must has, among all the other features, a
uniform porous structure with highly interconnected pores and must
shows an optimal degradation proﬁle [13,32,33].
Both porosity and degradation results, clearly indicate that the scaf-
fold C shows, among the obtained scaffolds, physicochemical features
potentially suitable for tissue engineering applications. For this reason,
only this scaffold was further investigated.
3.5. Atomic force microscopy (AFM) analysis and compression mechanical
studies
Nanoindentation experiment (performed with atomic force micros-
copy) of the local elastic modulus of PHEA-PLA-MA scaffold (sample
C) has showed a value of 1.25 ± 0.5 GPa that is higher than that report-
ed in the literature (0.1–1 MPa) for soft materials, like hydrogels, pro-
duced with various natural or synthetic polymers, whose major
drawback is the lack of mechanical resistance [34–36].
On the other hand, the elastic modulus of PHEA-PLA-MA scaffold is
lower than that of equine decellularized bone (used as a comparisonntaining different concentrations of PHEA-PLA-MA andNaClwith different grain size, after
Fig. 3. SEM images of sections of porous scaffold (samples A and C).
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sensitivity).
The bulk elastic modulus, calculated as the slope of the stress/strain
curve, resulted to be 48.33 ± 12.11 MPa.
3.6. Dexamethasone incorporation and release studies
The EE% of dexamethasone resulted to be 60 ± 5%.
The release proﬁle of dexamethasone from PHEA-PLA-MA scaffold C
in DPBS pH 7.4 is reported in Fig. 5.
As it can be observed, there is only an initial and slight burst effect
(lower than 10%) and then the release of the anti-inﬂammatory drug
continues until 150 h.
3.7. Chondrocyte incorporation
In order to evaluate if scaffold C is able to host chondrocytes for a po-
tential cartilage regeneration, bovine articular chondrocytes have been
seeded onto the scaffold, both with and without dexamethasone, and
their metabolic activity has been determined by MTS assay after 7 and
14 days of culture. Fig. 6 shows that the metabolic activity of the cells
cultured in the presence of scaffold is always comparable to that of pos-
itive control (about 80%), i.e. cells cultured in bidimensional conditions
in the culture plate. In addition, since not signiﬁcant difference (p N
0.05) has been observed for drug loaded and drug unloaded scaffolds,
the presence of dexamethasone does not inﬂuence viability of
chondrocytes.
The increase in cell viability between 7 and 14 days of culture was
signiﬁcant only for the control (p b 0.05) thus meaning that probablyFig. 4. Percent ofweight recovered after treatment of scaffolds A and Cwith DPBS alone (a) or incells are not proliferating into the scaffolds due to the high seeding
density.
In fact, in Fig. 7 it is possible to observe that many cells are present
into the scaffolds and that they take contact with the biomaterial
through several protrusions, thusmeaning that chondrocytes are recog-
nizing it as a substrate suitable for their adhesion.
These results conﬁrm the cytocompatibility of PHEA-PLA-MAporous
scaffold along with its cell adhesiveness.
4. Discussions
The grafting of PLA to PHEA backbone allows the obtainment of the
PHEA-PLA copolymer which is insoluble in water and shows still hy-
droxyl groups exploitable for further chemical derivatization.
Indeed, in our previous works, free primary hydroxyl groups of
PHEA in PHEA-PLA copolymer have been already exploited to covalently
bind bioactivemolecules such as heparin or anti-inﬂammatory drugs [6,
18]. In addition, high solubility of PHEA-PLA in cytocompatible organic
solvents, like dimethyl sulfoxide or N-methyl-2-pyrrolidone, allows to
prepare injectable in situ gel forming solutions able to release drugs in
a controlled manner [37].
To obtain a photo-crosslinkable copolymer, PHEA-PLAwas function-
alized with methacrylic anhydride (MA) and the obtained copolymer
was named PHEA-PLA-MA.
We have demonstrated that it is possible to obtain chemical net-
works after UV exposure of PHEA-PLA-MA organic solutions containing
NaCl particles with controlled granulometry. These networks give rise
to the formation of porous scaffolds when washed with water.
NaCl has been used as a porogen since it is not soluble in DMSO and
after the crosslinking process, it remains entrapped into the polymerthe presence of esterase (50 U/ml) (b) as a function of time and respect to startingweight.
Fig. 5. Release of dexamethasone in DPBS pH 7.4 from PHEA-PLA-MA scaffold (sample C).
Fig. 6. Cell viability (expressed as % of control viability) of chondrocytes cultured into
PHEA-PLA-MA scaffolds in the presence or not of dexamethasone after 7 and 14 days of
culture.
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water allows the dissolution of salt and the formation of a highly porous
structure.
By changing the copolymer concentration and theNaCl grain sizewe
obtained a series of scaffolds with different morphological
characteristics.
However, as already stated, only scaffolds obtained with NaCl at
lower grain size (sample A and C) show a uniform and reproducible
porosity.
Probably, during washing, the removal of coarse particles of salt (in
samples B and D) causes a deformation of the polymer network and a
collapse of the porous structure.
For the porosity analysis, scaffolds are immersed into a liquid able to
penetrate into the porous three-dimensional structure without causing
swelling of the scaffold itself.
Indeed, the rationale of the method is that the liquid should ﬁll the
void spaces (pores) when the scaffold is immersed into it, in such a
way that the difference of volume of the liquid before and after the scaf-
fold immersion, is directly proportional to the porosity of the scaffold it-
self. If a swelling process occurs, the amount of liquid into the scaffold is
greater than that necessary to occupy the voids and the analysis is not
correct. In our experiment, the liquid employed was ethylene glycol,
since this liquid does not swell the scaffolds. Moreover, results obtained
with the liquid displacementmethod were also conﬁrmed by analyzing
the samples with helium pycnometer by using the method reported by
Ho et al. [27].
This analysis gives information not only on the entity of the porosity
but also on the interconnection of the pores which is of crucial impor-
tance for the diffusion of both oxygen and nutrients.
The difference in porosity between sample A and C could be due to
the different concentration of PHEA-PLA-MA in the paste employed
for UV irradiation (see Table 1). Probably, the lower polymer concentra-
tion in sample C allows the formation of a less compact polymeric net-
work and a more porous structure after salt removal.
The differences in the degradation proﬁle between sample A and C
are due probably to a greater clearance of the degradation products
caused by higher porosity of sample C. In fact, after an initial lag time
for this scaffold, there is an increase in the degradation rate. This hy-
pothesis seems to be conﬁrmed by the analysis of the curves.
For the sample A, the process of elimination of degradation products
is not completely concomitant with the degradation process itself and
the loss on weight is lower.
Porosity data and degradation proﬁle of scaffold C suggest that this
sample is suitable for a potential application in cartilage regeneration.
For this reason, scaffold C has been chosen to evaluate its mechanical
properties, ability to incorporate and release dexamethasone, and to
allow the viability of articular bovine chondrocytes.We have demonstrated that simply by taking in contact the sample
with an organic solution of dexamethasone it is possible to obtain
high efﬁciency of incorporation of the drug. The presence of acetone in
dexamethasone solution allows the swelling of PHEA-PLA-MA scaffold
thus determining an efﬁcient drug incorporation.
Since the release proﬁle shows only a moderate burst effect and a
prolonged dexamethasone release, it reasonable to suppose that the
drug establishes hydrophobic interactions with the PLA chains and is
retained in the polymeric network once the scaffold is submerged in
DPBS pH 7.4.
Nanoindentation experiments performed on a biomaterial by using
atomic forcemicroscopy (AFM), give informationmainly onmechanical
properties of themicroenvironment encountered by the cells after their
seeding and shed light on possible interactions between the cells and
the material itself.
Results obtained suggest that PHEA-PLA-MA scaffold (sample
C) could be recognized by chondrocytes as a suitable substrate for
their adhesion.
To evaluate if this scaffold could be implanted in the osteochondral
region for the treatment of osteoarthritis, it is also important to study
its brittleness in bulk.
Indeed, as above reported, AFM gives information concerning only
the micrometric elastic modulus, which is important to understand
the interactions between cells and scaffold, but it is not suitable to ob-
tain information about bulk mechanical properties of a biomaterial.
For this reason, compression mechanical studies have been per-
formed on scaffold C swollen in DPBS pH 7.4.
Obtained results agree with those reported in the literature for sim-
ilar scaffolds [38,39] (obtained by employing polyesters as starting ma-
terials) and conﬁrm a potential use of this scaffold as substitute of
damaged cartilage.
Dexamethasone, chosen as an example of drug employed in the
treatment of osteoarthritis, has been loaded into sample C by incubating
the scaffoldwith a solution of drug in acetone (10mg/ml). Thanks to the
amphiphilic properties of PHEA-PLA-MA, the scaffold, when treated
with the organic solution of drug, swells thus allowing a penetration
of drug molecules into the polymeric network. The amount of incorpo-
rated dexamethasone was 85% w/w respect to the initial amount incu-
bated with the scaffold.
The release proﬁle shows that there is only an initial and slight burst
effect (b10%), thus demonstrating that only a little amount of dexa-
methasone migrates on the scaffold surface during the drying process
and then it is ready for a fast release.
Probably this phenomenon could be due to PLA lipophilic chains that
competewith the acetone in the retention of drug during the removal of
organic solvent.
Fig. 7. SEM images of bovine articular chondrocytes cultured for 14 days in PHEA-PLA-MA scaffolds without (A) and with dexamethasone (B).
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release proﬁle appears particularly interesting since it could guarantee
the presence of the drug in the target site in the ﬁrst days after the scaf-
fold implantation.
Three-dimensional culture study demonstrated that bovine
chondrocytes can grow into the scaffold with a good spreading and via-
bility proﬁle as demonstrated by MTS and SEM analysis.
5. Conclusions
By a simple and reproducible chemistry, it is possible to obtain a
photocrosslinkable copolymer with a polyaminoacid/polyester struc-
ture, named PHEA-PLA-MA, that has been employed to produce a vari-
ety of porous scaffolds.
It has been demonstrated that the physicochemical properties of
these scaffolds can be simply tailored by varying some parameters
such as polymer concentration and granulometry of porogen. In partic-
ular, it has been shown that it is possible to obtain a scaffold having op-
timal degradation proﬁle, porosity and mechanical properties, able to
incorporate and to control the release of dexamethasone and to act as
a three dimensional support for the culture of bovine articular
chondrocytes. In light of these results, PHEA-PLA-MA scaffold seems
an optimal biomaterial for potential cartilage regeneration.
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